作者: Victoria M Raymond , Stacy W Gray , Sameek Roychowdhury , Steve Joffe , Arul M Chinnaiyan
DOI: 10.1093/JNCI/DJV351
关键词:
摘要: Abstract Precision oncology holds great potential to improve patient therapies and outcomes. Tumor sequencing is rapidly moving into clinical care as our understanding of the cancer genome availability targeted increase. Analysis most informative when paired with germline genomic DNA delineate inherited somatic variants. Although tumor-only analysis remains common methodology for numerous reasons, it identify clinically significant Here, we provide anticipatory guidance points consider laboratories clinicians regarding findings in tumor sequencing.